Core Viewpoint - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for overseas listing applications for 11 companies, focusing on compliance, ownership structure, and business operations [1][2][3]. Group 1: Supplementary Material Requirements - For Avita, the requirements include clarifying the legality and fairness of past capital increases and share transfers, particularly regarding transactions at nominal or zero consideration, and the existence of shareholding proxies [1][14]. - For TuoSiDa, the focus is on the specific use of raised funds, the proportion of domestic versus overseas use, and whether necessary approvals for overseas investments have been obtained [2][5]. - For TianXiaXiu, the company must provide detailed operational information regarding its advertising and consulting services, along with legal opinions from lawyers [2][6]. - For JunSai Bio, the requirements include clarifying the actual controller's permanent residency status abroad and any historical shareholding proxies [2][9]. Group 2: Compliance and Legal Opinions - Companies are required to provide legal opinions confirming the compliance of their business operations with foreign investment regulations, particularly concerning sensitive sectors like stem cells and gene therapy [7][16]. - The CSRC emphasizes the need for companies to disclose any potential legal issues related to share pledges or freezes that may affect the listing process [10][18]. - Companies must also clarify their operational activities related to data protection and user information management, especially in the context of digital products and services [14][8]. Group 3: Ownership and Control Structure - Companies must explain discrepancies between their current and post-listing controlling shareholder structures, particularly in relation to the disclosures made in their prospectuses [2][14]. - The requirements include a thorough examination of the historical decisions made by the board and shareholder meetings to ascertain control rights [2][14]. - Companies are also asked to confirm whether their major shareholders are subject to any legal restrictions on ownership [13][17]. Group 4: Financial and Operational Transparency - Companies must detail the pricing basis for any recent share transfers and whether there are any irregularities or potential conflicts of interest [9][17]. - The CSRC requires companies to disclose their fundraising plans, including the expected amount and the implications of exercising any over-allotment options [12][18]. - Companies are also asked to provide insights into their business models, including customer and supplier relationships, and how these align with their market positioning [18].
证监会对阿维塔、天下秀、君赛生物等11家企业出具补充材料要求